OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ANRO

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Alto Neuroscience (ANRO) Earnings Date & Reports

Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANRO is expected to report earnings to fall 1.54% to -63 cents per share on November 18

Alto Neuroscience ANRO Stock Earnings Reports

Q3'25

Est.

$-0.64

Q2'25

Missed

by $0.05

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.06

The last earnings report on August 13 showed earnings per share of -64 cents, missing the estimate of -60 cents. With 36.32K shares outstanding, the current market capitalization sits at 99.37M.

View a ticker or compare two or three

Compare

ANRO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ANRO
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANRO showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

369 South San Antonio Road

Phone

+1 650 200-0412

Employees

Web

https://www.altoneuroscience.com